Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, T-Cell, Peripheral × CHOP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma 1

Interventions

Vincristine 7 Cyclophosphamide 7 10-propargyl-10-deazaaminopterin 7 Prednisone 6 Doxorubicin 6 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5 romidepsin 3 belinostat 3 Gemcitabine 3 liposomal doxorubicin 2 duvelisib 1 Vitamin B 12 1 MLN 8237 1 Folic Acid 1 Etoposide 1 E7777 fusion protein 1 Decitabine 1 CHOP protocol 1 Brentuximab Vedotin 1 Bendamustine Hydrochloride 1 BAEC protocol 1 Alemtuzumab 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00970385 2009-09-09

LTP

University Hospital, Grenoble

Phase 3 Completed

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡